Open

Schizophrenia and Clozapine Study

The purpose of this research study is to understand how an antipsychotic medication (clozapine) improves schizophrenia symptoms. We will study this through stem cells that mimic brain cell function, which we collect through a blood draw. We will also look for genetic causes that may be associated with clozapine response.

Age & Gender

18 years ~ 99 years
Male, Female, Gender Inclusive

Visit Availability

Standard business hours (M-F, 8-5)
Extended hours (M-F, early morning or evening)
Weekend hours, if needed
Visits can be combined with regular clinical appointments

Location

North Carolina (Statewide), Pennsylvania

What will be asked of you

At the study visit, you will provide a blood sample and complete two assessments.

Incentives

$50 gift card

In-person visits:
1

Total length of participation:
one study visit

Looking for Specific Volunteers

Able to participate:

You have been diagnosed with schizophrenia
You have been prescribed clozapine

Not eligible if:

You are under the age of 18

Contact the Team

Visit Location

Contact & Visit Location

Primary Contact

Dr Rose Mary Xavier
cnv@unc.edu
(919) 843-5743

Primary Visit Location

Carrington Hall (UNC-Chapel Hill, School of Nursing)
120 Medical Dr, Chapel Hill, NC 27514, USA

Additional Study Information

Principal Investigator

Rose Mary Xavier
School of Nursing

Study Type

Clinical or Medical
Observational

Study Topics

Chronic Conditions
Genetics and Genetic Disorders
Mental and Emotional Health

IRB Number

21-1293

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.